Celldex Therapeutics, Inc. (CLDX) vs Harmony Biosciences Holdings, Inc. (HRMY)
- Celldex Therapeutics, Inc. CLDX 27.53 −4.84%
- Harmony Biosciences Holdings, Inc. HRMY 38.20 −0.18%
Celldex Therapeutics, Inc. and Harmony Biosciences Holdings, Inc. are both Biotechnology companies. Celldex Therapeutics, Inc. and Harmony Biosciences Holdings, Inc. are of similar size ($2.3B and $2.2B). Celldex Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 12.2×. Harmony Biosciences Holdings, Inc. grew revenue faster over the last twelve months: 24.3% against −88.3%. Harmony Biosciences Holdings, Inc. has the higher net margin (18.9% vs −33,883.8%) and the higher return on invested capital (29.7% vs 0.00%). Across the 18 metrics below, Harmony Biosciences Holdings, Inc. leads on 15 and Celldex Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | CLDX | HRMY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 75.42% | 65.16% |
| Operating margin | (36,733.82%) | 24.03% | 0.00% |
| Net margin | (33,883.77%) | 18.88% | 0.00% |
| Free cash flow margin | (27,294.81%) | 36.99% | 0.00% |
| Return on equity | (43.88%) | 20.46% | (56.36%) |
| Return on assets | (40.76%) | 14.61% | (48.04%) |
| Return on invested capital | 0.00% | 29.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack